The first prospective study to evaluate the visual function and optical quality in patients with epiphora before and after lacrimal surgery.
Swiss-based Novartis Pharmaceuticals has acquired rights to commercialize Luxturna—Spark Therapeutics’ gene therapy for inherited retinal dystrophy—outside of the United States.
This study compared the incidence of epithelial erosions 1 year after transepithelial photorefractive keratectomy (PRK) versus alcohol-assisted PRK.
This week, a father creates a brilliant game to help his daughter learn Braille before she goes blind, Novartis and Roche duke it out in Italian courts and a new OCT technology scans the entire eye in unprecedented detail.
A patient with atrophic dry AMD and severe vision loss has regained central visual perception after receiving Prima, a vision restoration system by Pixium Vision.
Using data from the Gutenberg Health Study, researchers examined the effect of systemic anti-hypertensive medications on IOP.
This prospective trial compared the healing times of clear corneal incisions after femtosecond laser-assisted versus steel bevel knife-assisted cataract surgery.